OBJECTIVES: This study was conducted to assess the ill-defined relationship between sleep quality and multiple, specific domains of cognitive function in patients with cirrhosis. METHODS: A comprehensive battery of neuropsychological tests (divided into six neurocognitive domains) and a standardized, validated measure of sleep quality (Pittsburgh Sleep Quality Index [PSQI]) were administered to patients with cirrhosis and without evidence of overt hepatic encephalopathy, recruited from liver transplant and advanced liver disease clinics (n = 34). An inflammatory bowel disease (IBD) control group (n = 23) was similarly recruited and evaluated to control for the secondary effect of a chronic illness on cognition. PSQI global and component scores were used to predict cognitive function in each neurocognitive domain, using linear regression. RESULTS: Global PSQI scores were significantly higher (indicating poorer sleep quality) in the cirrhosis group (median [range] = 10 [1-19]) than in IBD controls = 5 (1-14); p = 0.002). After controlling for age and education, short duration of sleep was associated with impaired memory for patients with cirrhosis; the use of soporific agents was associated with poor visual-perceptual function in patients with IBD. CONCLUSIONS: Poor sleep was associated with worsening of the already impaired cognitive function of patients with cirrhosis.
OBJECTIVES: This study was conducted to assess the ill-defined relationship between sleep quality and multiple, specific domains of cognitive function in patients with cirrhosis. METHODS: A comprehensive battery of neuropsychological tests (divided into six neurocognitive domains) and a standardized, validated measure of sleep quality (Pittsburgh Sleep Quality Index [PSQI]) were administered to patients with cirrhosis and without evidence of overt hepatic encephalopathy, recruited from liver transplant and advanced liver disease clinics (n = 34). An inflammatory bowel disease (IBD) control group (n = 23) was similarly recruited and evaluated to control for the secondary effect of a chronic illness on cognition. PSQI global and component scores were used to predict cognitive function in each neurocognitive domain, using linear regression. RESULTS: Global PSQI scores were significantly higher (indicating poorer sleep quality) in the cirrhosis group (median [range] = 10 [1-19]) than in IBD controls = 5 (1-14); p = 0.002). After controlling for age and education, short duration of sleep was associated with impaired memory for patients with cirrhosis; the use of soporific agents was associated with poor visual-perceptual function in patients with IBD. CONCLUSIONS: Poor sleep was associated with worsening of the already impaired cognitive function of patients with cirrhosis.
Entities:
Keywords:
Minimal hepatic encephalopathy; cognitive impairment and cirrhosis; hepatic encephalopathy; poor sleep quality in cirrhosis
Authors: Sara Montagnese; Benita Middleton; Ali R Mani; Debra J Skene; Marsha Y Morgan Journal: Am J Gastroenterol Date: 2010-03-23 Impact factor: 10.864
Authors: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei Journal: Hepatology Date: 2002-03 Impact factor: 17.425
Authors: Jasmohan S Bajaj; Leroy R Thacker; David Leszczyszyn; Samuel A Taylor; Douglas M Heuman; Shekar Raman; Richard K Sterling; Muhammad S Siddiqui; R Todd Stravitz; Arun J Sanyal; Puneet Puri; Velimir Luketic; Scott Matherly; Michael Fuchs; Melanie B White; Nicole A Noble; Ariel B Unser; James B Wade Journal: Clin Gastroenterol Hepatol Date: 2014-08-23 Impact factor: 11.382
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Eva Szigethy; Francis Lotrich; Andrea F DiMartini Journal: Dig Dis Sci Date: 2014-11-30 Impact factor: 3.199